Title | Type | SJR | H index | Total Docs. (2019) | Total Docs. (3years) | Total Refs. (2019) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2019) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Perspectives in Medicinal Chemistry | journal | 4.450 Q1 | 17 | 0 | 2 | 0 | 31 | 2 | 0.00 | 0.00 | |
2 | Journal for ImmunoTherapy of Cancer | journal | 4.194 Q1 | 117 | 336 | 336 | 13307 | 3108 | 310 | 9.55 | 39.60 | |
3 | Protein and Cell | journal | 2.827 Q1 | 94 | 102 | 305 | 3333 | 1548 | 211 | 5.73 | 32.68 | |
4 | npj Vaccines | journal | 2.465 Q1 | 47 | 49 | 101 | 2565 | 551 | 99 | 5.64 | 52.35 | |
5 | Theranostics | journal | 2.348 Q1 | 158 | 544 | 971 | 33438 | 8717 | 946 | 8.50 | 61.47 | |
6 | Emerging Microbes and Infections | journal | 2.212 Q1 | 94 | 170 | 406 | 7651 | 2117 | 330 | 4.95 | 45.01 | |
7 | PLoS Neglected Tropical Diseases | journal | 2.148 Q1 | 163 | 730 | 2615 | 36846 | 11189 | 2558 | 4.01 | 50.47 | |
8 | Molecular Therapy - Nucleic Acids | journal | 2.089 Q1 | 95 | 280 | 489 | 14829 | 3241 | 480 | 7.05 | 52.96 | |
9 | npj Systems Biology and Applications | journal | 2.043 Q1 | 35 | 37 | 96 | 1754 | 466 | 96 | 4.45 | 47.41 | |
10 | Nanotechnology, Science and Applications | journal | 2.004 Q1 | 35 | 4 | 22 | 261 | 292 | 22 | 7.00 | 65.25 | |
11 | Emerging Contaminants | journal | 1.993 Q1 | 36 | 32 | 48 | 2018 | 384 | 47 | 13.00 | 63.06 | |
12 | Particle and Fibre Toxicology | journal | 1.922 Q1 | 119 | 46 | 166 | 2848 | 1276 | 162 | 7.71 | 61.91 | |
13 | Acta Pharmaceutica Sinica B | journal | 1.792 Q1 | 99 | 98 | 252 | 6275 | 1922 | 235 | 7.16 | 64.03 | |
14 | Expert Review of Vaccines | journal | 1.746 Q1 | 105 | 102 | 353 | 9704 | 1450 | 312 | 4.40 | 95.14 | |
15 | Vaccines | journal | 1.743 Q1 | 85 | 213 | 180 | 14257 | 929 | 172 | 4.30 | 66.93 | |
16 | International Journal of Neuropsychopharmacology | journal | 1.695 Q1 | 125 | 59 | 367 | 3337 | 1646 | 355 | 4.14 | 56.56 | |
17 | Human Genomics | journal | 1.594 Q1 | 68 | 66 | 121 | 1521 | 418 | 117 | 3.31 | 23.05 | |
18 | PharmacoEconomics | journal | 1.453 Q1 | 118 | 123 | 348 | 5332 | 1167 | 303 | 3.08 | 43.35 | |
19 | Applied and Translational Genomics | journal | 1.423 Q1 | 25 | 0 | 32 | 0 | 124 | 27 | 0.00 | 0.00 | |
20 | F1000Research | journal | 1.357 Q1 | 105 | 688 | 2119 | 34597 | 7166 | 2038 | 2.96 | 50.29 | |
21 | Journal of Nanobiotechnology | journal | 1.335 Q1 | 109 | 124 | 271 | 6672 | 1919 | 268 | 7.25 | 53.81 | |
22 | Cancer Nanotechnology | journal | 1.299 Q1 | 36 | 11 | 32 | 781 | 199 | 29 | 5.00 | 71.00 | |
23 | Nanotheranostics | journal | 1.271 Q1 | 32 | 24 | 64 | 1469 | 316 | 63 | 4.94 | 61.21 | |
24 | Altex | journal | 1.270 Q1 | 64 | 70 | 127 | 3181 | 620 | 108 | 4.45 | 45.44 | |
25 | EPMA Journal | journal | 1.263 Q1 | 52 | 36 | 95 | 2328 | 681 | 92 | 7.11 | 64.67 | |
26 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 1.257 Q1 | 47 | 51 | 150 | 2583 | 478 | 148 | 2.99 | 50.65 | |
27 | Biomarker Insights | journal | 1.253 Q1 | 40 | 16 | 73 | 836 | 288 | 73 | 3.84 | 52.25 | |
28 | Pharmaceuticals | journal | 1.245 Q1 | 87 | 182 | 309 | 14776 | 1474 | 298 | 4.69 | 81.19 | |
29 | Clinical and Experimental Vaccine Research | journal | 1.243 Q1 | 19 | 18 | 39 | 560 | 150 | 37 | 3.85 | 31.11 | |
30 | CNS Neuroscience and Therapeutics | journal | 1.241 Q1 | 91 | 140 | 364 | 7729 | 1288 | 305 | 3.61 | 55.21 | |
31 | Therapeutic Advances in Neurological Disorders | journal | 1.240 Q1 | 68 | 74 | 161 | 4511 | 736 | 149 | 5.20 | 60.96 | |
32 | Cancer Chemotherapy and Pharmacology | journal | 1.239 Q1 | 122 | 257 | 766 | 8806 | 2472 | 746 | 3.09 | 34.26 | |
33 | Frontiers in Pharmacology | journal | 1.228 Q1 | 154 | 1533 | 2951 | 98306 | 13190 | 2884 | 4.40 | 64.13 | |
34 | Clinical and Translational Science | journal | 1.175 Q1 | 60 | 83 | 182 | 2393 | 570 | 154 | 3.14 | 28.83 | |
35 | Antibiotics | journal | 1.173 Q1 | 77 | 267 | 186 | 15719 | 790 | 183 | 4.34 | 58.87 | |
36 | Cancer Biology and Therapy | journal | 1.116 Q1 | 130 | 153 | 416 | 6212 | 1445 | 411 | 3.41 | 40.60 | |
37 | Human Vaccines and Immunotherapeutics | journal | 1.088 Q1 | 93 | 399 | 1279 | 16236 | 3399 | 1007 | 2.46 | 40.69 | |
38 | International Journal of Pharmaceutics | journal | 1.081 Q1 | 258 | 882 | 2496 | 46619 | 12609 | 2471 | 5.26 | 52.86 | |
39 | Drug Delivery | journal | 1.072 Q1 | 95 | 124 | 748 | 5665 | 3777 | 748 | 5.17 | 45.69 | |
40 | International Journal of Nanomedicine | journal | 1.061 Q1 | 179 | 686 | 1714 | 36656 | 9268 | 1709 | 5.43 | 53.43 | |
41 | Core Evidence (discontinued) | journal | 1.054 Q1 | 29 | 0 | 10 | 0 | 53 | 10 | 5.60 | 0.00 | |
42 | Biomedicine and Pharmacotherapy | journal | 1.050 Q1 | 149 | 1372 | 4075 | 73103 | 18721 | 4063 | 4.66 | 53.28 | |
43 | Journal of Food and Drug Analysis | journal | 1.043 Q1 | 79 | 92 | 364 | 3840 | 1891 | 362 | 5.44 | 41.74 | |
44 | Toxins | journal | 1.034 Q1 | 116 | 756 | 1321 | 48590 | 5317 | 1277 | 3.72 | 64.27 | |
45 | Life Sciences | journal | 1.031 Q1 | 191 | 869 | 1480 | 47559 | 5725 | 1477 | 3.80 | 54.73 | |
46 | PPAR Research | journal | 1.025 Q1 | 59 | 14 | 75 | 453 | 261 | 73 | 3.27 | 32.36 | |
47 | Pharmacogenomics and Personalized Medicine | journal | 0.967 Q1 | 37 | 34 | 69 | 2240 | 271 | 66 | 3.76 | 65.88 | |
48 | Infection and Drug Resistance | journal | 0.966 Q1 | 65 | 390 | 350 | 15234 | 1171 | 341 | 3.31 | 39.06 | |
49 | Results in Pharma Sciences | journal | 0.963 Q1 | 19 | 0 | 3 | 0 | 21 | 3 | 0.00 | 0.00 | |
50 | Pharmacology Research and Perspectives | journal | 0.953 Q1 | 43 | 94 | 228 | 3628 | 577 | 225 | 2.19 | 38.60 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®